1. Home
  2. CATY vs NAMS Comparison

CATY vs NAMS Comparison

Compare CATY & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cathay General Bancorp

CATY

Cathay General Bancorp

HOLD

Current Price

$50.24

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$31.31

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATY
NAMS
Founded
1962
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
4.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CATY
NAMS
Price
$50.24
$31.31
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$50.80
$46.40
AVG Volume (30 Days)
424.4K
764.0K
Earning Date
01-22-2026
02-25-2026
Dividend Yield
2.68%
N/A
EPS Growth
9.40
N/A
EPS
4.33
N/A
Revenue
$711,617,000.00
$35,243,000.00
Revenue This Year
$18.83
N/A
Revenue Next Year
$8.37
$10.46
P/E Ratio
$11.72
N/A
Revenue Growth
N/A
4.91
52 Week Low
$36.06
$14.06
52 Week High
$51.95
$42.00

Technical Indicators

Market Signals
Indicator
CATY
NAMS
Relative Strength Index (RSI) 53.73 34.65
Support Level $48.74 $30.97
Resistance Level $51.32 $32.45
Average True Range (ATR) 1.08 1.59
MACD 0.03 -0.29
Stochastic Oscillator 69.62 17.72

Price Performance

Historical Comparison
CATY
NAMS

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: